- Using a nasal swab for quick and convenient specimen collection
- Getting a quick result within 15-30 minutes
- Providing patients with the option to self-collect their nasal sample
- Allowing decentralized testing or access to testing in areas where laboratory testing is not available
Product Overview
The product is intended for the qualitative detection of nucleocapsid antigen present in human nasal samples. This test is intended to detect antigen from in individuals suspected of infection or with known or suspected exposure to the infection. This product is intended for professional use in laboratory and Point of Care environments, or self-collection under the supervision of a healthcare worker.
benifits of the test
Compared to existing Rapid Antigen Test, Roche Rapid Antigen Test Nasal collects the sample from the front area of the nose instead of the nasopharynx. This is a simplified and faster testing procedure.This method can help reduce overall patient discomfort, particularly in sensitive individuals such as children, elderly people and/or people with disabilities.
![surface antigen (208-215) [Hepatitis B Virus]](https://cdn11.bigcommerce.com/s-2kvb5rm600/images/stencil/500x659/products/27656/24312/TargetMol-768x384__12443.1665998863__67539.1666015704.png?c=1 "surface antigen (208-215) [Hepatitis B Virus]")
![MHC class II antigen (45-57) [Homo sapiens]](https://cdn11.bigcommerce.com/s-2kvb5rm600/images/stencil/500x659/products/55517/52173/TargetMol-768x384__12443.1665998863__23191.1666081327.png?c=1 "MHC class II antigen (45-57) [Homo sapiens]")